Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients. (8th February 2021)

• Record Type: Journal Article
• Authors: Abdelbasset, Walid Kamal; Nambi, Gopal; Elsayed, Shereen H.; Moawd, Samah A.; Ibrahim, Ahmed A.; Verma, Anju; Tantawy, Sayed A.; Kamel, Dalia M.; Saleh, Ayman K.; Aldhafian, Osama R.; Nwihadh, Naif Bin
• Other Names: Liu Zhengwen Academic Editor.
• Is Part Of: Disease markers. Volume 2021(2021)
• Publication Date: 2021-02-08
• Subjects: Diagnosis -- Periodicals; Biochemical markers -- Periodicals; Pathology -- Periodicals; 616
• DOI: 10.1155/2021/8866093
• Languages: English
• ISSNs: 0278-0240

Abstract

Abstract : Sarcopenia is the most common feature of hepatic cirrhosis characterized by progressive loss of muscle mass and function and increases permanently the mortality and morbidity rates among those patients. The incidence of sarcopenia in cirrhotic patients ranged 40-70% associating with impaired quality of life and augmented rates of infection. Based on these issues, this review is aimed at determining the prevalence and main causes of sarcopenia among cirrhotic patients and recognizing the recent diagnostic and physical treatment modalities that prevent risk factors for sarcopenia in those patients. No ideal modality is currently demonstrated for diagnosing sarcopenia in hepatic diseases, particularly cirrhosis; however, recent studies reported different diagnostic modalities for muscle function in different individuals including handgrip strength, skeletal muscle index, six-min walk test, liver frailty index, short physical performance battery, and radiological assessments for quadriceps and psoas muscles. Exercise training and therapeutic nutrition are strongly recommended for controlling sarcopenia in cirrhotic patients. The exercise program is designed and carried out on a frequent basis within an extensive scheduled time aimed at improving functional performance, aerobic capacity, and healthy conditions. Finally, a combination of exercise training and therapeutic nutrition is powerfully recommended to control sarcopenia in cirrhosis.